{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:36:02Z","timestamp":1769607362443,"version":"3.49.0"},"reference-count":26,"publisher":"LLC Obyedinennaya Redaktsiya","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ter. arkh."],"published-print":{"date-parts":[[2016]]},"DOI":"10.17116\/terarkh201688743-48","type":"journal-article","created":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T11:15:57Z","timestamp":1469013357000},"page":"43","source":"Crossref","is-referenced-by-count":0,"title":["Late myelotoxicity of high-dose chemotherapy according to the modified NHL-BFM-90 program in adult patients with diffuse large B-cell lymphoma"],"prefix":"10.26442","volume":"88","author":[{"given":"E. I.","family":"Dorokhina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. U.","family":"Magomedova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. N.","family":"Dvirnyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. V.","family":"Galtseva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. A.","family":"Glinkina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. M.","family":"Kulikov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. N.","family":"Obukhova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. K.","family":"Kravchenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18344","reference":[{"key":"key-10.17116\/terarkh201688743-48-1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-2094"},{"key":"key-10.17116\/terarkh201688743-48-2","unstructured":"Magomedova A. Diffuse large \u0412-cell lymphosarcoma of lymphoid organs: clinical forms and treatment. [dissertation]. Moscow; 2008. (In Russ.)"},{"key":"key-10.17116\/terarkh201688743-48-3","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(11)61040-4"},{"key":"key-10.17116\/terarkh201688743-48-4","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.056531"},{"key":"key-10.17116\/terarkh201688743-48-5","unstructured":"Magomedova A, Kravchenko S, Kremenetskaya A, Zvonkov E, Baryakh E, Mangasarova Ya, Vorob\u2019ev A. The nine-year experience in the treatment of patients with diffuse large lymphosarcoma. Terapevticheskii arkhiv. 2011;7:5-10. (In Russ.)"},{"key":"key-10.17116\/terarkh201688743-48-6","doi-asserted-by":"crossref","unstructured":"Smith C. Hematopoietic stem cells and hematopoiesis. Cancer Control. 2003;10(1):9-16.","DOI":"10.1177\/107327480301000103"},{"key":"key-10.17116\/terarkh201688743-48-7","unstructured":"Gale R. Antineoplastic chemotherapy myelosuppression: Mechanisms and new approaches (Keynote address). Exp Hematol. 1985;13:3-7."},{"key":"key-10.17116\/terarkh201688743-48-8","unstructured":"Neben S, Hellman S, Montgomery M, Ferrara J, Mauch P, Hemman S. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents. Exp Hematol. 1993;21(1):156-162."},{"key":"key-10.17116\/terarkh201688743-48-9","unstructured":"Minderman H, Linssen P, van der Lely N, Wessels J, Boezeman J, de Witte T, Haanen C. Toxicity of idarubicin and doxorubicin towards normal and leukemic human bone marrow progenitors in relation to their proliferative state. Leukemia. 1994;8(3):382-387."},{"key":"key-10.17116\/terarkh201688743-48-10","doi-asserted-by":"crossref","unstructured":"Schein PS, Winokur SH. Immunosuppressive and cytotoxic chemotherapy: long-term complications. Ann Intern Med. 1975;82(1):84-95.","DOI":"10.7326\/0003-4819-82-1-84"},{"key":"key-10.17116\/terarkh201688743-48-11","doi-asserted-by":"crossref","unstructured":"Trainor KJ, Seshadri RS, Morley AA. Residual marrow injury following cytotoxic drugs. Leuk Res. 1979;3(4):205-210.","DOI":"10.1016\/0145-2126(79)90043-2"},{"key":"key-10.17116\/terarkh201688743-48-12","doi-asserted-by":"crossref","unstructured":"Lohrmann HP. The problem of permanent bone marrow damage after cytotoxic drug treatment. Oncology. 1984;41(3):180-184.","DOI":"10.1159\/000225819"},{"key":"key-10.17116\/terarkh201688743-48-13","doi-asserted-by":"crossref","unstructured":"Groopman JE, Itri LM. Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst. 1999;91(19):1616-1634.","DOI":"10.1093\/jnci\/91.19.1616"},{"key":"key-10.17116\/terarkh201688743-48-14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2004.06.019"},{"key":"key-10.17116\/terarkh201688743-48-15","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-013-2074-2"},{"key":"key-10.17116\/terarkh201688743-48-16","doi-asserted-by":"publisher","DOI":"10.1097\/moh.0b013e328353c714"},{"key":"key-10.17116\/terarkh201688743-48-17","doi-asserted-by":"publisher","DOI":"10.1097\/moh.0000000000000012"},{"key":"key-10.17116\/terarkh201688743-48-18","unstructured":"Gribanova E. Hematopoiesis after allogeneic and autologous bone marrow transplantation. [dissertation]. Moscow; 2003. (In Russ.)"},{"key":"key-10.17116\/terarkh201688743-48-19","unstructured":"Gribanova E, Glasko E, Lyubimova L, Kaplanskaya I, Petrov A, Lebedev E. Histology of the bone marrow in patients with acute leukemia at various times after bone marrow transplantation. Problemy gematologii I perelivaniya krovi. 2002;4:13-20. (In Russ.)"},{"key":"key-10.17116\/terarkh201688743-48-20","unstructured":"O\u00b4Flaherty E, Sparrow R, Szer J. Bone marrow stromal function from patients after bone marrow transplantation. Bone Marrow Transplant. 1995;15:207-212."},{"key":"key-10.17116\/terarkh201688743-48-21","doi-asserted-by":"publisher","DOI":"10.1097\/mph.0000000000000295"},{"key":"key-10.17116\/terarkh201688743-48-22","doi-asserted-by":"crossref","unstructured":"Schmitz LL, McClure JS, Litz CE, Dayton V, Weisdorf DJ, Parkin JL, Brunning RD. Morphologic and quantitave changes in blood and marrow cells following growth factor therapy. Am \u041e \u0421lin Pathol. 1994;101:67-75.","DOI":"10.1093\/ajcp\/101.1.67"},{"key":"key-10.17116\/terarkh201688743-48-23","unstructured":"Gaidamaka N, Parovichnikova E, Zavalishina L, Garmaeva T, Gaponova T, Troitskaya V. Long-term bone marrow aplasia after chemotherapy in patients with acute leukemia. Terapevticheskii arkhiv. 2010;7:12-18. (In Russ.)"},{"key":"key-10.17116\/terarkh201688743-48-24","unstructured":"Garmaeva T, Kulikov S, Karyakin A et al. Monitoring the risk factors and indicators of infection in hematological patients with hepatitis B and C. Gematologiya i transfuziologiya. 2006;1:23-27. (In Russ.)"},{"key":"key-10.17116\/terarkh201688743-48-25","unstructured":"Dolgikh T. Clinico-pathological examination of bone marrow microenvironment and erythrone in aggressive and indolent non-Hodgkin\u2019s lymphomas. [dissertation]. Novosibirsk; 2011. (In Russ.)"},{"key":"key-10.17116\/terarkh201688743-48-26","unstructured":"Shirin A, Frenkel\u2019 M. Current diagnosis of myelodysplastic syndromes adults. Klinicheskaya onkogematologiya. Fundamental\u2019nye issledovaniya I klinicheskaya praktika. 2010;3:3. (In Russ.)"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T21:25:26Z","timestamp":1593379526000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/terapevticheskij-arkhiv\/2016\/7\/downloads\/ru\/1004036602016071043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016]]}},"alternative-id":["terarkh201688743-48"],"URL":"https:\/\/doi.org\/10.17116\/terarkh201688743-48","relation":{},"ISSN":["0040-3660"],"issn-type":[{"value":"0040-3660","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}